意大利北部患者就诊、皮肤活检使用与皮肤恶性黑色素瘤发病率和死亡率:趋势与相关性
该生态学研究利用意大利艾米利亚-罗马涅大区四个癌症登记处覆盖2,696,000人口的数据,分析2003-2017年皮肤科门诊就诊率、皮肤活检率、原位及不同厚度侵袭性皮肤恶性黑色素瘤发病率与死亡率趋势。结果显示发病率显著上升,原位黑色素瘤增幅最大(男性EAAPC 10.2,女性6.9),女性死亡率显著下降(-2.3),男性下降不显著;皮肤科门诊就诊率与活检率相关,但活检占就诊比例历年恒定。作者认为发病率上升趋势至少部分真实,过度诊断若存在应归因于患者就诊增加而非皮肤科活检阈值降低。
要点
- 原位黑色素瘤发病率增幅最大(男性EAAPC 10.2,女性6.9),其次为厚度<0.8 mm者(男性9.1,女性5.2)。
- 女性死亡率显著下降(EAAPC -2.3),男性下降不显著。
- 皮肤科门诊就诊率与活检率相关,但活检占就诊比例历年恒定(男性0.182-0.216,女性0.157-0.191)。
核心结论
- 在意大利,皮肤恶性黑色素瘤发病率上升趋势至少部分真实;过度诊断若存在,应归因于患者到皮肤科就诊增加,而非皮肤科活检阈值降低。
研究设计与样本
- 生态学研究,利用意大利艾米利亚-罗马涅大区四个癌症登记处覆盖2,696,000人口的数据,分析2003-2017年皮肤恶性黑色素瘤发病数据。
- 皮肤科门诊就诊率和皮肤活检率采用大区门诊医疗数据库计算,所有率均进行年龄标准化。
- 趋势用估计的年平均百分比变化(EAAPC)描述,相关性用Spearman相关系数检验。
主要发现
- 皮肤恶性黑色素瘤发病率显著上升,原位黑色素瘤增幅最大(EAAPC:男性10.2,女性6.9),其次为厚度<0.8 mm者(EAAPC:男性9.1,女性5.2),但大多数厚度≥0.8 mm亚组发病率也显著增长。
- 死亡率在女性中显著下降(EAAPC -2.3),在男性中下降不显著。
- 皮肤科门诊就诊率EAAPC男性1.7、女性1.2,皮肤活检率EAAPC男性1.8、女性0.9。
- 两性中年度皮肤科门诊就诊率均与皮肤活检率相关。
- 皮肤活检占皮肤科门诊就诊的比例历年恒定(范围:男性0.182-0.216,女性0.157-0.191)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The global increase in incidence of cutaneous malignant melanoma (CMM) occurring in the past decades has been partly attributed to increased diagnostic scrutiny of early lesions, with a potential phenomenon of overdiagnosis. The reported positive linear relation between skin biopsy rate and incidence of early CMM is compatible with this hypothesis. OBJECTIVES: We explored the ecological association between the trends in annual dermatologic office visit rates, skin biopsy rates, incidence rates of in situ and invasive CMM by tumour thickness category, and CMM mortality rates in the Emilia-Romagna Region (northern Italy). METHODS: Four cancer registries covering a population of 2,696,000 provided CMM incidence data for the years 2003-2017. Dermatologic office visit rates and skin biopsy rates were calculated using the Regional outpatient care database. All rates were age-standardized. Trends were described with the estimated average annual per cent change (EAAPC). Correlations were tested with the Spearman correlation coefficient. RESULTS: Incidence increased significantly. The increase was steeper for in situ CMM (EAAPC: men, 10.2; women, 6.9) followed by CMM <0.8 mm thick (9.1; 5.2), but the rates grew significantly for most subgroups of CMMs ≥0.8 mm thick. Mortality decreased significantly among women (-2.3) and non-significantly among men. For dermatologic office visit rate and skin biopsy rate the EAAPC were, respectively, 1.7 and 1.8 for men and 1.2 and 0.9 for women. Annual dermatologic office visit rate correlated with skin biopsy rate in both sexes. However, the proportion of skin biopsies out of dermatologic office visits was constant across the years (range: men, 0.182-0.216; women, 0.157-0.191). CONCLUSIONS: In Italy, the increasing CMM incidence trend is, at least in part, genuine. Overdiagnosis-if any-is due to an increased patient presentation at dermatologic offices and not to a lower dermatologic threshold to perform biopsy.
引用
- Bucchi L, Mancini S, Zamagni F, et al. Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations. J Eur Acad Dermatol Venereol. 2022. PMID: 36181283. doi:10.1111/jdv.18635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。